Cargando…
Pharmacogenetic actionability and medication prescribing in people with cystic fibrosis
Although major advancements have been made in the therapeutics for people with cystic fibrosis (PwCF), many still require the use of multiple medications to manage acute exacerbations of disease and maintain health. Iterative trial and error processes of pharmacotherapeutic management can be optimiz...
Autores principales: | Anderson, Justin D., Davis, Brittney H., Giang, Gracie, Jones, April, Lee, Cameron R., Parker, Kennedy, Searcy, Heather, Benner, Kim, Limdi, Nita A., Guimbellot, Jennifer S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087076/ https://www.ncbi.nlm.nih.gov/pubmed/36760155 http://dx.doi.org/10.1111/cts.13479 |
Ejemplares similares
-
Evaluation of population‐level pharmacogenetic actionability in Alabama
por: Davis, Brittney H., et al.
Publicado: (2021) -
Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
por: Limdi, Nita A.
Publicado: (2012) -
Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant Epilepsy
por: Davis, Brittney H., et al.
Publicado: (2021) -
Potential pathogenicity of Inquilinus limosus in a pediatric patient with cystic fibrosis
por: Poore, T. Spencer, et al.
Publicado: (2018) -
Human Nasal Epithelial Organoids for Therapeutic Development in Cystic Fibrosis
por: Liu, Zhongyu, et al.
Publicado: (2020)